Medindia

X

Orchid Gets Approval for Antibiotic Drug from FDA

by VR Sreeraman on  June 21, 2007 at 7:14 PM Drug News   - G J E 4
Orchid Gets Approval for Antibiotic Drug from FDA
Chennai:- Pharma major Orchid Chemicals and Pharmaceuticals Ltd has getting approval from US Food and Drug Administration (FDA) for its abbreviated new anti-biotic drug application for Cefepime injection.
Advertisement

Cefepime injection is a life saving cephalosporin antibiotic drug with an annual sale of $190 million, and is used in hospital settings.

Advertisement
"Orchid's Cefepime approval for the US generic market is prestigious, given that it is the first abbreviated new drug application (ANDA) approval received for this product from the FDA. The product has been supplied to Apotex for distribution by them in the US," Orchid's Managing Director K. Raghavendra Rao said here Thursday.

The product is available in three dosage strengths, 500 mg/vial, 1 gram/vial, and 2 grams/vial.

The Chennai-based Orchid has filed 40 ANDAs comprising 29 antibiotic and 11 non-antibiotic products so far with the FDA. It has received approvals for 19 ANDAs, including Cefepime.

Source: IANS
LIN/M
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All